Correlation Between GlaxoSmithKline PLC and IShares IBonds
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and IShares IBonds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and IShares IBonds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and iShares iBonds Dec, you can compare the effects of market volatilities on GlaxoSmithKline PLC and IShares IBonds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of IShares IBonds. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and IShares IBonds.
Diversification Opportunities for GlaxoSmithKline PLC and IShares IBonds
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between GlaxoSmithKline and IShares is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and iShares iBonds Dec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares iBonds Dec and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with IShares IBonds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares iBonds Dec has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and IShares IBonds go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and IShares IBonds
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the IShares IBonds. In addition to that, GlaxoSmithKline PLC is 3.66 times more volatile than iShares iBonds Dec. It trades about -0.12 of its total potential returns per unit of risk. iShares iBonds Dec is currently generating about 0.08 per unit of volatility. If you would invest 2,329 in iShares iBonds Dec on August 29, 2024 and sell it today you would earn a total of 94.00 from holding iShares iBonds Dec or generate 4.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. iShares iBonds Dec
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| iShares iBonds Dec |
GlaxoSmithKline PLC and IShares IBonds Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and IShares IBonds
The main advantage of trading using opposite GlaxoSmithKline PLC and IShares IBonds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, IShares IBonds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares IBonds will offset losses from the drop in IShares IBonds' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| IShares IBonds vs. Global X Funds | IShares IBonds vs. US Treasury 12 | IShares IBonds vs. Tidal Trust II | IShares IBonds vs. Franklin Liberty Treasury |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |